Indian stocks opened lower on Friday after enjoying gains over the last three sessions.
The Sensex index on the BSE fell by 333 points, representing a 0.4% decrease, to reach 76,709 in the initial hours of trading. Similarly, the NSE Nifty index declined by 73 points, or 0.3%, to stand at 23,238.
Reliance Industries rose by 2.5% as it announced record-breaking quarterly profits. In contrast, Infosys experienced a sharp 5% drop despite its impressive third-quarter financial results for the fiscal year 2025, which exceeded market expectations across all metrics.
Axis Bank saw a significant 4.4% decrease due to reporting a modest increase in its profits for the December quarter. Meanwhile, LTIMindtree experienced a 3% decline following a report of a 7.14% reduction in consolidated net profit for the third quarter, falling short of forecasts.
Conversely, Spencer's Retail increased by 3.2% after reducing its quarterly net loss, and Sun Pharmaceutical saw a 1.2% rise following the announcement that its subsidiary, Taro Pharmaceuticals, had agreed to acquire Antibe Therapeutics, a clinical-stage biotechnology firm located in Ontario, Canada.
The material has been provided by InstaForex Company - www.instaforex.com
The Sensex index on the BSE fell by 333 points, representing a 0.4% decrease, to reach 76,709 in the initial hours of trading. Similarly, the NSE Nifty index declined by 73 points, or 0.3%, to stand at 23,238.
Reliance Industries rose by 2.5% as it announced record-breaking quarterly profits. In contrast, Infosys experienced a sharp 5% drop despite its impressive third-quarter financial results for the fiscal year 2025, which exceeded market expectations across all metrics.
Axis Bank saw a significant 4.4% decrease due to reporting a modest increase in its profits for the December quarter. Meanwhile, LTIMindtree experienced a 3% decline following a report of a 7.14% reduction in consolidated net profit for the third quarter, falling short of forecasts.
Conversely, Spencer's Retail increased by 3.2% after reducing its quarterly net loss, and Sun Pharmaceutical saw a 1.2% rise following the announcement that its subsidiary, Taro Pharmaceuticals, had agreed to acquire Antibe Therapeutics, a clinical-stage biotechnology firm located in Ontario, Canada.
The material has been provided by InstaForex Company - www.instaforex.com